SEC Info - Akero Therapeutics, Inc. - ‘ARS’ for 12/31/22

SEC Info℠

Home

Help

Please Sign In

Akero Therapeutics, Inc. – ‘ARS’ for 12/31/22

On: Friday, 4/28/23, at 4:40pm ET · Effective: 4/28/23 · For: 12/31/22 · Accession #: 950170-23-15897 · File #: 1-38944

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/28/23  Akero Therapeutics, Inc.          ARS        12/31/22    1:2M                                     Donnelley … Solutions/FA

Annual Report to Security Holders

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: ARS         Annual Report to Security Holders -- 2022_10-k_ars   PDF   1.51M

This is a PDF Document.

	Download this Adobe® Acrobat® `.pdf` document

	Get Adobe® Acrobat® Reader™, if you haven’t done so already, in order to read this document.

↑Top

Filing Submission 0000950170-23-015897 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Akero Therapeutics, Inc. – ‘ARS’ for 12/31/22

On: Friday, 4/28/23, at 4:40pm ET · Effective: 4/28/23 · For: 12/31/22 · Accession #: 950170-23-15897 · File #: 1-38944

Previous ‘ARS’: None · Next & Latest: ‘ARS’ on 4/26/24 for 12/31/23

Annual Report to Security HoldersFiling Table of Contents

This is a PDF Document.

Annual Report to Security Holders

Filing Table of Contents